Pfizer 2014 Annual Report Download - page 69

Download and view the complete annual report

Please find page 69 of the 2014 Pfizer annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 75

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75

PFIZER ANNUAL REVIEW 2014 www.pzer.com/annual 69
ANNUAL REVIEW 2014
Our World > Patient Engagement
The Pzer Meds app is designed to provide quick access to
information for patients taking Pzer prescription medicines.
By simply scanning or entering the barcode on their prescription
medicine pack, patients can access helpful, up-to-date information
about their medicine and/or their medical condition. Launched in
Australia and with pilots underway to expand this platform around
the world, the app is available for free download in Australia from
iTunes or Google Play.
PFIZER MEDS APP
Sickle cell disease is a devastating illness marked by excruciating
pain “crises.” Studying the disease in patients often means
intercepting them at the worst of times, in emergency rooms — a
big reason why sickle cell clinical trials have often been hobbled by
low recruitment and retention rates. To tackle this problem, Pzer
partnered with a health care ethnography rm to “shadow” sickle
cell patients in their homes and other places throughout their day
to gather real-life insights. We learned more about these patients’
concerns and their strengths, what motivates them to volunteer
for clinical trials, and what practices work — and do not work — for
recruiting sickle cell clinical trial volunteers. These insights are
being used to update Pzer’s approach to sickle cell patient clinical
trial recruitment.
“We need to show patients that we understand their point of view, and
to explain better how to consider if a clinical trial may be right for them.”
— Krupa Sivamurthy, M.D., Medical Director, Sickle Cell Disease
SICKLE CELL DISEASE CLINICAL
TRIAL RECRUITMENT
PATIENT ENGAGEMENT